Charles Schwab Investment Management Inc Deciphera Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$13.58 - $17.36 $219,642 - $280,780	16,174 Added 3.14%	531,475 $8.36 Million
Q4 2023 Feb 06, 2024	BUY	$10.11 - $16.54 $138,668 - $226,862	13,716 Added 2.73%	515,301 $8.31 Million
Q3 2023 Nov 08, 2023	BUY	$12.46 - $15.48 $103,729 - $128,871	8,325 Added 1.69%	501,585 $6.38 Million
Q2 2023 Aug 09, 2023	BUY	$13.28 - $15.96 $486,247 - $584,375	36,615 Added 8.02%	493,260 $6.95 Million
Q1 2023 May 11, 2023	BUY	$14.26 - $22.1 $1.38 Million - $2.14 Million	96,827 Added 26.91%	456,645 $7.06 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $185,922 - $238,380	12,520 Added 3.6%	359,818 $5.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $236,953 - $387,202	19,140 Added 5.83%	347,298 $6.43 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $481,272 - $738,549	52,829 Added 19.19%	328,158 $4.32 Million
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $130,330 - $210,767	-18,971 Reduced 6.45%	275,329 $2.55 Million
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $66,759 - $321,917	8,670 Added 3.04%	294,300 $2.88 Million
Q3 2021 Nov 16, 2021	BUY	$26.46 - $37.15 $234,885 - $329,780	8,877 Added 3.21%	285,630 $9.71 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $208,457 - $305,393	6,369 Added 2.36%	276,753 $10.1 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $450,388 - $632,596	11,151 Added 4.3%	270,384 $12.1 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $332,415 - $424,941	6,421 Added 2.54%	259,233 $14.8 Million
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $3.58 Million - $4.76 Million	81,803 Added 47.84%	252,812 $13 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $1.72 Million - $3.02 Million	46,488 Added 37.33%	171,009 $10.2 Million
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $281,718 - $581,363	8,377 Added 7.21%	124,521 $5.13 Million
Q4 2019 Feb 07, 2020	BUY	$31.7 - $69.93 $238,701 - $526,572	7,530 Added 6.93%	116,144 $7.23 Million
Q3 2019 Nov 08, 2019	BUY	$19.95 - $38.85 $444,206 - $865,034	22,266 Added 25.79%	108,614 $3.69 Million
Q2 2019 Aug 09, 2019	BUY	$21.05 - $26.21 $284,764 - $354,568	13,528 Added 18.58%	86,348 $1.95 Million
Q1 2019 May 14, 2019	BUY	$20.65 - $29.55 $65,749 - $94,087	3,184 Added 4.57%	72,820 $1.69 Million
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $21,369 - $40,476	-1,120 Reduced 1.58%	69,636 $1.46 Million
Q3 2018 Nov 13, 2018	BUY	$33.57 - $42.1 $342,011 - $428,914	10,188 Added 16.82%	70,756 $2.74 Million
Q2 2018 Aug 08, 2018	BUY	$20.06 - $44.95 $537,146 - $1.2 Million	26,777 Added 79.24%	60,568 $2.38 Million
Q1 2018 May 07, 2018	BUY	$20.04 - $29.71 $114,969 - $170,446	5,737 Added 20.45%	33,791 $678,000
Q4 2017 Jan 17, 2018	BUY	$16.54 - $24.2 $464,013 - $678,906	28,054	28,054 $636,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account